Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2004-2-11
pubmed:abstractText
Only a few studies have been reported on CTL epitope peptides restricted with alleles other than HLA-A2 and -A24. The HLA-A11, -A31, and -A33 alleles share similar binding motifs with HLA-A3 and -A68 alleles, and, thus, are classified as an HLA-A3 supertype. This study tried to identify CTL epitope peptides as vaccine candidates sharing by HLA-A3(+), -A11(+), -A31(+), and -A33(+) cancer patients.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
1078-0432
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
10
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1112-20
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:14871991-Alleles, pubmed-meshheading:14871991-Animals, pubmed-meshheading:14871991-CD8-Positive T-Lymphocytes, pubmed-meshheading:14871991-COS Cells, pubmed-meshheading:14871991-Cancer Vaccines, pubmed-meshheading:14871991-Cell Line, Tumor, pubmed-meshheading:14871991-Clinical Trials as Topic, pubmed-meshheading:14871991-DNA, Complementary, pubmed-meshheading:14871991-Dose-Response Relationship, Drug, pubmed-meshheading:14871991-Epitopes, T-Lymphocyte, pubmed-meshheading:14871991-HLA-A Antigens, pubmed-meshheading:14871991-HLA-A11 Antigen, pubmed-meshheading:14871991-HLA-A3 Antigen, pubmed-meshheading:14871991-Humans, pubmed-meshheading:14871991-Immunotherapy, pubmed-meshheading:14871991-Leukocytes, Mononuclear, pubmed-meshheading:14871991-Neoplasms, pubmed-meshheading:14871991-Peptides, pubmed-meshheading:14871991-Protein Binding, pubmed-meshheading:14871991-Skin Neoplasms, pubmed-meshheading:14871991-T-Lymphocytes, Cytotoxic, pubmed-meshheading:14871991-Vaccines, Subunit
pubmed:year
2004
pubmed:articleTitle
Identification of peptide vaccine candidates sharing among HLA-A3+, -A11+, -A31+, and -A33+ cancer patients.
pubmed:affiliation
Department of Immunology, Kurume University, 67 Asahi-machi, Kurume, Fukuoka 830-0011, Japan.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't